Acadia Healthcare (NASDAQ:ACHC – Get Free Report) had its price target lowered by equities researchers at Barclays from $83.00 to $76.00 in a research note issued to investors on Monday, Benzinga reports. The brokerage presently has an “overweight” rating on the stock. Barclays‘s price target would suggest a potential upside of 21.78% from the stock’s current price.
Several other brokerages have also issued reports on ACHC. Royal Bank of Canada restated an “outperform” rating and set a $94.00 price target on shares of Acadia Healthcare in a research note on Friday, September 20th. Cantor Fitzgerald restated a “neutral” rating and set a $90.00 price target on shares of Acadia Healthcare in a research note on Monday, August 19th. Finally, Deutsche Bank Aktiengesellschaft boosted their price target on Acadia Healthcare from $70.00 to $75.00 and gave the company a “hold” rating in a research note on Friday, August 2nd. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and six have assigned a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $86.67.
View Our Latest Analysis on ACHC
Acadia Healthcare Price Performance
Acadia Healthcare (NASDAQ:ACHC – Get Free Report) last posted its quarterly earnings data on Wednesday, July 31st. The company reported $0.91 earnings per share for the quarter, topping the consensus estimate of $0.87 by $0.04. Acadia Healthcare had a positive return on equity of 11.42% and a negative net margin of 0.17%. The business had revenue of $796.00 million during the quarter, compared to analysts’ expectations of $784.38 million. During the same quarter in the previous year, the firm earned $0.92 EPS. The firm’s revenue was up 8.8% compared to the same quarter last year. On average, analysts anticipate that Acadia Healthcare will post 3.51 earnings per share for the current fiscal year.
Institutional Investors Weigh In On Acadia Healthcare
A number of large investors have recently bought and sold shares of ACHC. Harbor Capital Advisors Inc. acquired a new position in Acadia Healthcare during the 2nd quarter worth $800,000. TCW Group Inc. lifted its holdings in Acadia Healthcare by 63.8% during the 2nd quarter. TCW Group Inc. now owns 62,888 shares of the company’s stock worth $4,247,000 after buying an additional 24,487 shares in the last quarter. SG Americas Securities LLC lifted its holdings in Acadia Healthcare by 435.6% during the 2nd quarter. SG Americas Securities LLC now owns 18,227 shares of the company’s stock worth $1,231,000 after buying an additional 14,824 shares in the last quarter. Principal Financial Group Inc. lifted its holdings in Acadia Healthcare by 19.4% during the 2nd quarter. Principal Financial Group Inc. now owns 643,521 shares of the company’s stock worth $43,463,000 after buying an additional 104,359 shares in the last quarter. Finally, Iron Triangle Partners LP lifted its holdings in Acadia Healthcare by 3.5% during the 4th quarter. Iron Triangle Partners LP now owns 791,993 shares of the company’s stock worth $61,585,000 after buying an additional 26,789 shares in the last quarter.
About Acadia Healthcare
Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.
Featured Stories
- Five stocks we like better than Acadia Healthcare
- What is the Shanghai Stock Exchange Composite Index?
- Why Lennar Stock Could Be the Best Play in the Housing Market
- How to Calculate Inflation Rate
- 2 Energy Stocks Fueling the AI Datacenter Boom
- Consumer Discretionary Stocks Explained
- Will Marinus Pharmaceuticals Be the Next Big Winner in Biotech?
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.